Top brokers name 3 ASX shares to buy today 10 February 2021

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

According to a note out of UBS, its analysts have retained their buy rating but trimmed their price target on this biotherapeutics company’s shares to $339.00 ahead of its half year results release. The broker is expecting a solid half year update from CSL due partly to strong demand for seasonal flu vaccines. Looking to the full year, UBS believes CSL is on course to achieve it guidance in FY 2021. The CSL share price is trading at $276.16…